Global Thoracic Drainage Devices Market Overview:
Thoracic drainage devices are designed to remove air, liquids, and some solids from the pleural space of chest. Factors such as rising demand for minimally invasive surgeries, high prevalence of cardiovascular diseases and increase in burden of spontaneous pneumothorax are driving the growth of the thoracic drainage devices market. The rise in demand for minimally invasive procedures over open surgery is triggering a high market growth rate. Also, these procedures usually provide equivalent outcomes to traditional open surgery, along with offering significant benefits, like lower risk of complications, shorter length of stay, and lesser recuperation period. Increasing care provider's preference for minimally invasive procedures for a range of surgical applications which is expected to boost the demand for thoracic drainage devices globally in the forecast period.
Growth Drivers
- Rising Demand for Minimally Invasive Surgeries
- High Prevalence of Cardiovascular Diseases
- Increase Demand of Early Diagnosis and Treatment of Diseases
Market Trends
- Favorable Reimbursement Policies of the Government and Increasing Burden of Spontaneous Pneumothorax
Roadblocks
- Lack of Availability of Skilled Physicians
Opportunities
- Increasing Occurrences of Cardiovascular Diseases, High Blood Pressure, Diabetes and Obesity
Challenges
- Stringent Regulatory Guidelines
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are C. R. Bard, Inc. (United States), MAQUET Holding B.V. & Co. KG (Germany), Smiths Medical (United States), Teleflex Incorporated (United States), Vygon SA (France), Medtronic (United States), Cook Medical (United States), Utah Medical Products, Inc. (United States), ATMOS MedizinTechnik GmbH & Co. KG (Untied States) and Rocket Medical plc. (United Kingdom). Additionally, following companies can also be profiled that are part of our coverage like Sinapi Biomedical (South Africa) and Medela AG (Switzerland). Analyst at AMA Research see United States Players to retain maximum share of Global Thoracic Drainage Devices market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Thoracic Drainage Devices market. Considering Market by End User, the sub-segment i.e. Ambulance Services will boost the Thoracic Drainage Devices market.
What Can be Explored with the Thoracic Drainage Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Thoracic Drainage Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Thoracic Drainage Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Thoracic Drainage Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Thoracic Drainage Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Thoracic Drainage Devices Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.